Citizens Financial Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $510K | Buy |
6,154
+2,197
| +56% | +$182K | 0.01% | 465 |
|
|
2025
Q1 | $321K | Buy |
3,957
+111
| +3% | +$9K | 0.01% | 491 |
|
|
2024
Q4 | $346K | Sell |
3,846
-125
| -3% | -$11.3K | 0.01% | 454 |
|
|
2024
Q3 | $392K | Hold |
3,971
| – | – | 0.01% | 420 |
|
|
2024
Q2 | $368K | Buy |
3,971
+825
| +26% | +$76.5K | 0.01% | 417 |
|
|
2024
Q1 | $298K | Hold |
3,146
| – | – | 0.01% | 338 |
|
|
2023
Q4 | $281K | Sell |
3,146
-100
| -3% | -$8.93K | 0.01% | 345 |
|
|
2023
Q3 | $237K | Buy |
3,246
+100
| +3% | +$7.3K | 0.01% | 325 |
|
|
2023
Q2 | $262K | Buy |
+3,146
| New | +$262K | 0.01% | 338 |
|
|
2022
Q3 | – | Sell |
-3,740
| Closed | -$278K | – | 437 |
|
|
2022
Q2 | $278K | Sell |
3,740
-354
| -9% | -$26.3K | 0.01% | 360 |
|
|
2022
Q1 | $368K | Hold |
4,094
| – | – | 0.01% | 328 |
|
|
2021
Q4 | $458K | Hold |
4,094
| – | – | 0.02% | 302 |
|
|
2021
Q3 | $515K | Buy |
4,094
+2,461
| +151% | +$310K | 0.02% | 282 |
|
|
2021
Q2 | $221K | Buy |
1,633
+93
| +6% | +$12.6K | 0.01% | 333 |
|
|
2021
Q1 | $209K | Buy |
+1,540
| New | +$209K | 0.01% | 303 |
|
|
2020
Q3 | – | Sell |
-596
| Closed | -$67K | – | 956 |
|
|
2020
Q2 | $67K | Hold |
596
| – | – | ﹤0.01% | 422 |
|
|
2020
Q1 | $46K | Buy |
+596
| New | +$46K | ﹤0.01% | 441 |
|
|
2019
Q2 | – | Sell |
-400
| Closed | -$36K | – | 864 |
|
|
2019
Q1 | $36K | Buy |
+400
| New | +$36K | ﹤0.01% | 392 |
|